Apyx Medical Corporation is rolling out its first-ever direct-to-consumer brand campaign for Renuvion, a proprietary helium plasma and radiofrequency technology.

The #ThisIsMe campaign is aimed at U.S. consumers who are interested in a minimally invasive procedure with the Renuvion technology. The new campaign targets consumers with a variety of creative content that illustrates the goals of potential patients from different walks of life who want a younger and tighter-looking appearance of their neck and chin.

"In an era of superficial innovations, Renuvion goes beneath the surface to uplift, empower and reshape what's possible," says Jeff Hoffman, Vice President of Marketing, in a news release. "We are a brand that benefits patients physically with results that benefit them emotionally – creating confidence they never could have imagined. To connect with our patients on a personal level, the #ThisIsMe campaign speaks from their perspective."

This launch features national digital advertising, social media and a redesigned website, which is focused primarily on the consumer and features the creative content in the brand campaign. These assets are designed to raise awareness of Renuvion and highlight the benefits of the technology.

The Renuvion brand campaign is launching on the heels of Renuvion's two recent landmark US Food and Drug Administration (FDA) clearances including clearance for improving the appearance of loose skin on the chin and neck. 

"With the recent FDA clearances that Renuvion has received, it's important that Apyx Medical let potential patients know about its unique capabilities," says Todd Hornsby, Executive Vice President.  "Renuvion's safety and efficacy is based on years of scientific research and clinical evidence which is unique in this industry."